Irisoquin



Compound IDCDAMM02534
Common nameIrisoquin
IUPAC name2-hydroxy-5-methoxy-3-octadecylcyclohexa-2,5-diene-1,4-dione
Molecular formulaC25H42O4

Experimental data

Retention time3.84
Adduct[M+H]+
Actual mz407.318
Theoretical mz407.315
Error7.42
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score6.7893

Identifiers and class information

Inchi keyVOJSRSKBOJBZEK-UHFFFAOYSA-N
SmilesO=C1C=C(OC)C(=O)C(=C1O)CCCCCCCCCCCCCCCCCC
SuperclassOrganic oxygen compounds
ClassOrganooxygen compounds

Pharmacokinetic properties

Number of descriptor values(#stars)4
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)19
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)406.604
Computed dipole moment(dipole)2.186
Total solvent accessible surface area (SASA)905.643
Hydrophobic component of SASA (FOSA)731.752
Hydrophilic component of SASA (FISA)139.625
Pie component of the SASA (PISA)34.266
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)1583.72
Number of hydrogen bond donors (donorHB)1
Number of hydrogen bond acceptors (accptHB)5.5
Free energy of solvation of dipole (dip^2/V)0.0030174
Index of cohesive interaction in solids (ACxDN^.5/SA)0.006073
Globularity descriptor (glob)0.725539
Predicted polarizability in cubic angstroms (QPpolrz)45.354
Predicted hexadecane/gas partition coefficient (QPlogPC16)15.012
Predicted octanol/gas partition coefficient (QPlogPoct)18.365
Predicted water/gas partition coefficient (QPlogPw)5.772
Predicted octanol/water partition coefficient (QPlogPo/w)5.992
Predicted aqueous solubility (QPlogS)-7.612
Conformation-independent predicted aqueous solubility (CIQPlogS)-5.642
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-6.136
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)469.718
Predicted brain/blood partition coefficient (QPlogBB)-2.35
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)218.598
Predicted skin permeability, log Kp (QPlogKp)-2.148
PM3 calculated ionization potential (IP(ev))9.75
PM3 calculated electron affinity (EA(eV))1.77
Number of likely metabolic reactions (#metab)3
Prediction of binding to human serum albumin (QPlogKhsa)1.016
Predicted qualitative human oral absorption (HumanOralAbsorption)1
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)96.893
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)84.306
Number of nitrogen and oxygen atoms (#NandO)4
Number of violations of Lipinski’s rule of five (RuleOfFive)1
Number of violations of Jorgensen’s rule of three (RuleOfThree)1

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
P30307CDC25CDual specificity phosphatase Cdc25CT40569SEA
P09917ALOX5Arachidonate 5-lipoxygenaseT00140SEA
P10827THRAThyroid hormone receptor alphaT79591SEA
P10828THRBThyroid hormone receptor beta-1T98933SEA
P27695APEX1DNA-(apurinic or apyrimidinic site) lyaseT13348SEA
P08842STSSteryl-sulfataseT33489SEA
P30307CDC25CDual specificity phosphatase Cdc25CT40569SEA
P30307CDC25CDual specificity phosphatase Cdc25CT40569SEA
P10826RARBRetinoic acid receptor betaT61657SEA
O95136S1PR2Sphingosine 1-phosphate receptor Edg-5T47888SEA
Q9NQS5GPR84G-protein coupled receptor 84T98091SEA
Q9UJM8HAO1Hydroxyacid oxidase 1T63170SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T00140DI0037Asthma[ICD-11: CA23]P09917ALOX5
T00140DI0147Filariasis[ICD-11: 1F66]P09917ALOX5
T00140DI0403Thrombocytopenia[ICD-11: 3B64]P09917ALOX5
T79591DI0188Hyper-lipoproteinaemia[ICD-11: 5C80]P10827THRA
T79591DI0197Hypo-thyroidism[ICD-11: 5A00]P10827THRA
T98933DI0188Hyper-lipoproteinaemia[ICD-11: 5C80]P10828THRB
T13348DI0365Retinopathy[ICD-11: 9B71]P27695APEX1
T13348DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]P27695APEX1
T33489DI0022Allergic/hypersensitivity disorder[ICD-11: 4A80-4A8Z]P08842STS
T61657DI0225Kaposi sarcoma[ICD-11: 2B57]P10826RARB
T47888DI0419Ulcerative colitis[ICD-11: DD71]O95136S1PR2
T98091DI0199Idiopathic interstitial pneumonitis[ICD-11: CB03]Q9NQS5GPR84
T98091DI0417Type 2 diabetes mellitus[ICD-11: 5A11]Q9NQS5GPR84
T63170DI0201Inborn carbohydrate metabolism error[ICD-11: 5C51]Q9UJM8HAO1

Copyright © 2025